Kimialys recognized in Challenges’ top 100 startups list for 2023
news

Kimialys recognized in Challenges’ top 100 startups list for 2023

28/2/2024

•

By Cyril Gilbert

•

1 min read

We are thrilled to announce that Kimialys is part of Challenges' Challenges’ prestigious “Top 100 Startups Where to Invest” 2023 list.

This recognition highlights our team’s dedication to advance innovative diagnostic tests and support pharmaceutical companies in their drug development efforts. This achievement sets Kimialys as one of the most promising startups in its field, meeting the needs of the fast-growing in vitro diagnostic and biopharmaceutical industries.

For further information and to watch the 3 minute pitch of our CEO, Cyril Gilbert:

Watch the pitch

Subscribe to our newsletter!

Subscribe to our monthly newsletter and stay informed about the latest news, application notes, and insights from our activities.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Related posts

Discover all our news.

View all
Kimialys wins best scientific poster award at ALFC2024
Old
news

1 min read

Kimialys wins best scientific poster award at ALFC2024

We are thrilled to announce that Kimialys has been selected by DCN Dx for the best poster award at The Advanced Lateral Flow Conference (ALFC) 2024, which took place in San Diego on February 13-14. A special congratulations to Nicolas Heureux for his exceptional presentation!

Read more

Kimialys secures nearly one million euros for its industrial and business development
Old
news

5 min read

Kimialys secures nearly one million euros for its industrial and business development

Kimialys, a privately held French startup specialised in surface chemical treatment for innovative in vitro diagnostic assays and biosensing applications, today announced that it has successfully closed a funding round, raising nearly one million euros.

Read more

Join our newsletter to stay up to date on features and releases.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Thank you! Your submission has been received.
Oops! Something went wrong while submitting the form.
By clicking on "Accept all cookies", you agree to the storage of cookies on your device to improve site navigation, analyze site usage and assist us in our marketing efforts. See our Cookie policy for more information.
PreferencesDeclineAccept